Charles River Laboratories Pre-Tax Profit Margin 2010-2024 | CRL

Current and historical pre-tax profit margin for Charles River Laboratories (CRL) from 2010 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Charles River Laboratories pre-tax profit margin for the three months ending June 30, 2024 was .
Charles River Laboratories Pre-Tax Profit Margin Historical Data
Date TTM Revenue TTM Pre-Tax Income Pre-Tax Margin
2024-06-30 $4.08B $0.54B 13.27%
2024-03-31 $4.11B $0.55B 13.38%
2023-12-31 $4.13B $0.58B 14.10%
2023-09-30 $4.22B $0.62B 14.66%
2023-06-30 $4.18B $0.63B 15.03%
2023-03-31 $4.09B $0.64B 15.72%
2022-12-31 $3.98B $0.62B 15.67%
2022-09-30 $3.78B $0.54B 14.33%
2022-06-30 $3.69B $0.54B 14.70%
2022-03-31 $3.63B $0.53B 14.46%
2021-12-31 $3.54B $0.48B 13.56%
2021-09-30 $3.43B $0.49B 14.24%
2021-06-30 $3.27B $0.50B 15.27%
2021-03-31 $3.04B $0.46B 15.02%
2020-12-31 $2.92B $0.45B 15.25%
2020-09-30 $2.82B $0.38B 13.46%
2020-06-30 $2.75B $0.32B 11.57%
2020-03-31 $2.72B $0.29B 10.76%
2019-12-31 $2.62B $0.30B 11.59%
2019-09-30 $2.53B $0.27B 10.78%
2019-06-30 $2.45B $0.27B 11.14%
2019-03-31 $2.38B $0.28B 11.95%
2018-12-31 $2.27B $0.28B 12.40%
2018-09-30 $2.14B $0.28B 12.84%
2018-06-30 $2.02B $0.28B 13.61%
2018-03-31 $1.91B $0.28B 14.80%
2017-12-31 $1.86B $0.30B 15.99%
2017-09-30 $1.85B $0.29B 15.82%
2017-06-30 $1.81B $0.27B 15.04%
2017-03-31 $1.77B $0.25B 14.04%
2016-12-31 $1.68B $0.22B 13.26%
2016-09-30 $1.57B $0.21B 13.32%
2016-06-30 $1.49B $0.21B 14.01%
2016-03-31 $1.40B $0.22B 15.38%
2015-12-31 $1.36B $0.20B 14.31%
2015-09-30 $1.34B $0.19B 13.82%
2015-06-30 $1.32B $0.18B 13.35%
2015-03-31 $1.32B $0.17B 12.66%
2014-12-31 $1.30B $0.18B 13.71%
2014-09-30 $1.26B $0.16B 12.81%
2014-06-30 $1.22B $0.16B 13.10%
2014-03-31 $1.17B $0.15B 12.45%
2013-12-31 $1.17B $0.14B 11.93%
2013-09-30 $1.16B $0.14B 12.28%
2013-06-30 $1.14B $0.13B 11.11%
2013-03-31 $1.14B $0.13B 11.45%
2012-12-31 $1.13B $0.13B 11.42%
2012-09-30 $1.14B $0.14B 11.92%
2012-06-30 $1.14B $0.13B 11.67%
2012-03-31 $1.14B $0.14B 11.90%
2011-12-31 $1.14B $0.13B 11.72%
2011-09-30 $1.13B $-0.27B -23.99%
2011-06-30 $1.13B $-0.31B -27.06%
2011-03-31 $1.13B $-0.33B -28.90%
2010-12-31 $1.13B $-0.34B -29.54%
2010-09-30 $1.12B $0.07B 6.00%
2010-06-30 $1.14B $0.12B 10.07%
2010-03-31 $1.16B $0.14B 12.06%
2009-12-31 $1.17B $0.15B 12.89%
Sector Industry Market Cap Revenue
Medical Medical Services $9.742B $4.129B
Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $96.890B 12.02
Cencora (COR) United States $46.107B 17.62
DiDi Global (DIDIY) China $23.233B 0.00
ICON (ICLR) Ireland $18.679B 16.64
Revvity (RVTY) United States $15.535B 26.63
Avantor (AVTR) United States $15.498B 23.24
Natera (NTRA) United States $15.385B 0.00
Viatris (VTRS) United States $13.858B 4.22
BioMerieux (BMXMF) France $13.601B 0.00
Solventum (SOLV) United States $12.636B 0.00
CochLear (CHEOY) Australia $12.565B 0.00
Medpace Holdings (MEDP) United States $10.202B 28.74
Sonic Healthcare (SKHHY) Australia $8.273B 0.00
HealthEquity (HQY) United States $7.792B 42.29
Doximity (DOCS) United States $7.787B 49.34
Bausch + Lomb (BLCO) Canada $6.975B 32.47
Life Times (LTH) United States $4.762B 31.52
PACS (PACS) United States $4.502B 0.00
Sotera Health (SHC) United States $4.367B 23.36
Organon (OGN) United States $4.239B 4.28
Surgery Partners (SGRY) United States $3.778B 41.86
BrightSpring Health Services (BTSG) United States $3.070B 65.30
Ardent Health Partners (ARDT) United States $2.577B 0.00
Alignment Healthcare (ALHC) United States $2.546B 0.00
Concentras Parent (CON) United States $2.480B 0.00
Premier (PINC) United States $2.271B 11.34
GoodRx Holdings (GDRX) United States $2.254B 84.86
GeneDx Holdings (WGS) United States $2.057B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
Teladoc Health (TDOC) United States $1.575B 0.00
AMN Healthcare Services Inc (AMN) United States $1.507B 7.57
Progyny (PGNY) United States $1.425B 25.06
Establishment Labs Holdings (ESTA) $1.338B 0.00
Pediatrix Medical (MD) United States $1.319B 12.91
CareDx (CDNA) United States $1.228B 0.00
Agilon Health (AGL) United States $1.123B 0.00
Embecta (EMBC) United States $0.864B 5.76
InnovAge Holding (INNV) United States $0.822B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
SBC Medicals (SBC) United States $0.722B 0.00
Auna S.A (AUNA) Luxembourg $0.488B 0.00
Sonida Senior Living (SNDA) United States $0.483B 0.00
Enhabit (EHAB) United States $0.382B 33.04
DocGo (DCGO) United States $0.355B 13.35
COMPASS Pathways (CMPS) United Kingdom $0.309B 0.00
Sera Prognostics (SERA) United States $0.255B 0.00
ModivCare (MODV) United States $0.232B 7.37
Beauty Health (SKIN) United States $0.211B 0.00
Biodesix (BDSX) United States $0.195B 0.00
LifeMD (LFMD) United States $0.192B 0.00
Ascend Wellness Holdings (AAWH) United States $0.178B 0.00
MultiPlan (MPLN) United States $0.136B 0.00
Nutex Health (NUTX) United States $0.127B 0.00
So-Young (SY) China $0.092B 22.35
Harvard Apparatus Regenerative Technology (HRGN) United States $0.059B 0.00
Singular Genomics Systems (OMIC) United States $0.057B 0.00
OncoCyte (OCX) United States $0.049B 0.00
NeueHealth (NEUE) United States $0.041B 1.63
Co-Diagnostics (CODX) United States $0.039B 0.00
IceCure Medical (ICCM) Israel $0.036B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.027B 0.00
Pheton Holdings (PTHL) China $0.027B 0.00
Oncology Institute (TOI) United States $0.021B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
BioNexus Gene Lab (BGLC) $0.007B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00